NCI Research Specialist/Clinician Scientist Award for Urologic Oncology Research
NCI 泌尿肿瘤研究研究专家/临床科学家奖
基本信息
- 批准号:10640470
- 负责人:
- 金额:$ 11.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAdvocateAwardCaringCementationClinicalClinical InvestigatorClinical ResearchClinical SciencesClinical TrialsDedicationsFellowshipFinancial HardshipFinancial SupportIndividualIndustryInstitutionKidneyLeadLeadershipMentorshipOncologistOperating RoomsPatientsPlayProtocols documentationRenal MassRenal carcinomaResearchResearch PersonnelReview CommitteeRoleScientistSouthwest Oncology GroupSpecialistSurgeonTimeTranslational ResearchTravelUnited States National Institutes of HealthUrologic OncologyWorkanticancer researchcareer developmentimprintimprovedmeetingsmultidisciplinarynext generationovertreatmentpeerpressureprogramsprotocol developmenttranslational scientisttrial planningurologic
项目摘要
Project Summary
As a urologic oncologist, most of my peers have focused on operating as much as possible
with the hope their efforts could positively effect change on an individual level. During my NCI
Urologic Oncology Fellowship, I was drawn to the power of clinical discovery working alongside
clinical investigators. A surgeon has limited research paths to create paradigm shifts in the field
beyond the operating room, as industry often ignores many of the critical questions facing us.
Fortunately, the NIH Cooperative Group network trials provide an avenue for clinical scientists to
impact the field by interacting with likeminded individuals, patient advocates, translational
researchers, statisticians, and operational staff. By early engagement in SWOG, I have been
afforded the opportunity to participate and lead several clinical trials before taking larger roles in
translational research initiatives. This cemented my passion as a clinician scientist hoping to lead
new initiatives in kidney cancer. I am fortunate to have assumed Co-Chair responsibilities within
SWOG’s Renal Subcommittee and the NCI Renal Task Force. These leadership roles allow me to
imprint the next generation of clinical trials. This also includes my involvement with a small renal
mass trial aimed at reducing overtreatment, that was developed through a Clinical Trials Planning
Meeting by much of the Renal Task Force and has been prioritized within SWOG this year with
plans for GU Steering Committee review later this year. Despite receiving academic and leadership
recognition, my engagement in NCI clinical research throughtrial participation, administrative
efforts, mentorship of SWOG investigators, protocol development, and travel for bi-annual
meetings, there is limited institutional support at UCLA for these endeavors. Similarly, the NCI
sponsored trials have resulted in a financial burden to staff and this investigator, as compared to
industry trials. Participation has largely been a result of my passion to provide patients an
opportunity for improved care. The R50 Research Specialist Award mechanism recognizes the
critical role that individuals can play to advance clinical science and can significantly advance my
work. In particular, the financial support associated with this Award will further my engagement
in available NIH protocols, provide time for protocol development including our new Small Renal
Mass Concept, provide the means to travel to SWOG and Renal Task force meetings, and allow
designated protected time that SWOG and Renal Task Force leadership requires. This Award
would be instrumental in my academic career development during a time where the is increasing
pressure to produce clinically. I am thrilled for this opportunity and appreciate UCLA recognizing
my efforts with this nomination.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian Shuch其他文献
Brian Shuch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian Shuch', 18)}}的其他基金
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 11.47万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 11.47万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 11.47万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 11.47万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 11.47万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 11.47万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 11.47万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 11.47万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 11.47万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 11.47万 - 项目类别: